🔎 Trials Near Me

Home › Glioma › Tennessee › Memphis

Glioma clinical trials in Memphis, TN

3 studies for Glioma are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

RecruitingPhase 1/2
  • Saint Jude Children's Research Hospital, Memphis
12 Months – 21 Years · All sexes · Updated Sep 30, 2026 · NCT05099003

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

RecruitingPhase 1/2
  • St. Jude Children's Research Hospital, Memphis
Up to age 25 · All sexes · Updated Sep 25, 2026 · NCT04094610

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

RecruitingPhase 2
  • St. Jude Children's Research Hospital, Memphis
Up to age 3 · All sexes · Updated May 13, 2026 · NCT06528691

Glioma trials in other cities

Other studies in Memphis

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.